EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anticancer Effects of Abietane Diterpene 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus grandidentatus and Its Semi-Synthetic Analogs: An In Silico Computational Approach

Vera M S Isca iD, Przemysław Sitarek iD, Anna Merecz-Sadowska iD, Magdalena Małecka iD, Monika Owczarek iD, Joanna Wieczfińska iD, Radosław Zajdel iD, Paweł Nowak iD, Patricia Rijo iD, Tomasz Kowalczyk iD

Molecules · 2024

DOI: 10.3390/molecules29081807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Vera M S Isca und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, 1749-024 Lisbon, Portugal. Hauptthemen laut MEDLINE: Abietanes, Molecular Docking Simulation, Plectranthus, Diterpenes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FCT (Portugal), PhD grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The abietane diterpenoid 7α-acetoxy-6β-hydroxyroyleanone (Roy) isolated from Plectranthus grandidentatus demonstrates cytotoxicity across numerous cancer cell lines. To potentiate anticancer attributes, a series of semi-synthetic Roy derivatives were generated and examined computationally. ADMET predictions were used to evaluate drug-likeness and toxicity risks. The antineoplastic potential was quantified by PASS. The DFT models were used to assess their reactivity and stability. Molecular docking determined cancer-related protein binding. MS simulations examined ligand–protein stability. Additionally, network pharmacology was used to identify potential targets and signaling pathways. Favorable ADME attributes and acceptable toxicity profiles were determined for all compounds. Strong anticancer potential was shown across derivatives (Pa 0.819–0.879). Strategic modifications altered HOMO–LUMO gaps (3.39–3.79 eV) and global reactivity indices. Favorable binding was revealed against cyclin-dependent kinases, BCL-2, caspases, receptor tyrosine kinases, and p53. The ligand exhibited a stable binding pose in MD simulations. Network analysis revealed involvement in cancer-related pathways. In silico evaluations predicted Roy and derivatives as effective molecules with anticancer properties. Experimental progress is warranted to realize their chemotherapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AbietanesMolecular Docking SimulationPlectranthusDiterpenesHumansComputer SimulationAntineoplastic AgentsCell Line, TumorAntineoplastic Agents, PhytogenicMolecular Dynamics SimulationMolecular Structure

Stichwörter der Autor:innen

7α-acetoxy-6β-hydroxyroyleanonePlectranthus grandidentatusanticancer activity

Substanzen

AbietanesAntineoplastic AgentsAntineoplastic Agents, Phytogenic7alpha-acetoxy-6beta-hydroxyroyleanoneDiterpenes

Autor:innen und Institutionen

  • Center for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, 1749-024 Lisbon, Portugal.
  • Department of Medical Biology, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.
  • Department of Economic and Medical Informatics, University of Lodz, 90-214 Lodz, Poland.
  • Department of Allergology and Respiratory Rehabilitation, Medical University of Lodz, 90-725 Lodz, Poland.
  • Department of Physical Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163/165, 90-236 Lodz, Poland.
  • Łukasiewicz Research Network, Lodz Institute of Technology, Skłodowskiej-Curie 19/27, 90-570 Lodz, Poland.

ORCID-Profile: Vera M S Isca, Przemysław Sitarek, Anna Merecz-Sadowska, Magdalena Małecka, Monika Owczarek, Joanna Wieczfińska, Radosław Zajdel, Paweł Nowak, Patricia Rijo, Tomasz Kowalczyk

Förderung

  • FCT (Portugal)
  • PhD grant

Zitieren

APA

Isca, V. M. S., Sitarek, P., Merecz-Sadowska, A., Małecka, M., Owczarek, M., Wieczfińska, J., Zajdel, R., Nowak, P., Rijo, P., & Kowalczyk, T. (2024). Anticancer Effects of Abietane Diterpene 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus grandidentatus and Its Semi-Synthetic Analogs: An In Silico Computational Approach. Molecules. https://doi.org/10.3390/molecules29081807

Vancouver

Isca VMS, Sitarek P, Merecz-Sadowska A, Małecka M, Owczarek M, Wieczfińska J, et al. Anticancer Effects of Abietane Diterpene 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus grandidentatus and Its Semi-Synthetic Analogs: An In Silico Computational Approach. Molecules. 2024. doi:10.3390/molecules29081807

BibTeX
@article{Isca2024,
  author = {Isca, Vera M S and Sitarek, Przemysław and Merecz-Sadowska, Anna and Małecka, Magdalena and Owczarek, Monika and Wieczfińska, Joanna and Zajdel, Radosław and Nowak, Paweł and Rijo, Patricia and Kowalczyk, Tomasz},
  title = {Anticancer Effects of Abietane Diterpene 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus grandidentatus and Its Semi-Synthetic Analogs: An In Silico Computational Approach},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29081807}
}
Kostenlos starten →